Live website intelligence
AUSTEDO® XR: Tardive Dyskinesia and Huntington's Chorea Treatment
AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington
Last refresh
Updated 15d ago
Analyst read
Professional
Detected stack
Quick read
How to read austedo.com quickly
austedo.com looks like health & fitness. Traffic signals point to roughly 88.0K monthly visits. Current AI trust scoring is 15/100.
What to do next
- The stack appears to include React.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
51/56 fields populated (91%)
Providers with missing fields
View field-level status
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 5/5
All expected fields present
publisher: 3/5
Missing: directCount, resellerCount
files: 2/3
Missing: robotsSitemapUrls
traffic: 10/10
All expected fields present
whois: 6/6
All expected fields present
radar: 2/4
Missing: categories, sourceTimestamp
ai: 7/7
All expected fields present
Why this module matters
Business signals help answer “is this a real opportunity?”
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
- Trust score and sentiment are your first risk screen.
- Business summary and audience notes speed up qualification.
- Ads and monetization patterns reveal how the site captures value.
Business Intelligence
Business Profile
AUSTEDO XR is a prescription medication (deutetrabenazine extended-release) manufactured by Teva Pharmaceuticals, approved for treating both tardive dyskinesia and Huntington's disease chorea in adults. The website serves as a patient and healthcare provider resource for drug information, safety data, and treatment guidance.
Classification
Trust & Risk
Trust Assessment
Google Ads Transparency
Publisher Monetization
Monetization Signals
AI Visual Analysis
IAB Taxonomy
Business Insights
Business Model
Pharmaceutical/Medical - Branded Drug Marketing model detected
Trust Level
Low trust with 15/100 score
Audience
Adults diagnosed with Huntington's disease chorea or tardive dyskinesia, their caregivers, and healthcare providers (neurologists, psychiatrists) prescribing treatments for movement disorders
Keep exploring
Keep exploring from this report
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.